ATE260297T1 - Eine methode zur herstellung von igg - Google Patents

Eine methode zur herstellung von igg

Info

Publication number
ATE260297T1
ATE260297T1 AT01940271T AT01940271T ATE260297T1 AT E260297 T1 ATE260297 T1 AT E260297T1 AT 01940271 T AT01940271 T AT 01940271T AT 01940271 T AT01940271 T AT 01940271T AT E260297 T1 ATE260297 T1 AT E260297T1
Authority
AT
Austria
Prior art keywords
igg
igg fraction
iii
fraction
derived
Prior art date
Application number
AT01940271T
Other languages
English (en)
Inventor
Inger Andersson
Lars-Olof Lindquist
Original Assignee
Amersham Biosciences Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20279068&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE260297(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amersham Biosciences Ab filed Critical Amersham Biosciences Ab
Application granted granted Critical
Publication of ATE260297T1 publication Critical patent/ATE260297T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01940271T 2000-03-30 2001-03-29 Eine methode zur herstellung von igg ATE260297T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0001128A SE0001128D0 (sv) 2000-03-30 2000-03-30 A method of producing IgG
PCT/EP2001/003624 WO2001072844A2 (en) 2000-03-30 2001-03-29 A METHOD OF PRODUCING IgG

Publications (1)

Publication Number Publication Date
ATE260297T1 true ATE260297T1 (de) 2004-03-15

Family

ID=20279068

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01940271T ATE260297T1 (de) 2000-03-30 2001-03-29 Eine methode zur herstellung von igg

Country Status (15)

Country Link
US (1) US6835379B2 (de)
EP (1) EP1268551B1 (de)
JP (1) JP2003530326A (de)
CN (1) CN1419566A (de)
AT (1) ATE260297T1 (de)
AU (2) AU2001273907B2 (de)
BR (1) BRPI0109740B8 (de)
CA (1) CA2402784A1 (de)
DE (1) DE60102144T2 (de)
IL (1) IL151667A0 (de)
PT (1) PT1268551E (de)
RU (1) RU2266914C2 (de)
SE (1) SE0001128D0 (de)
TR (1) TR200400701T4 (de)
WO (1) WO2001072844A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100451031C (zh) * 2003-09-05 2009-01-14 东丽株式会社 生物体成分组成改变了的溶液的调制方法
ATE540050T1 (de) * 2003-09-05 2012-01-15 Toray Industries Verfahren zur herstellung einer proteomanalyse- lösung
EP1532983A1 (de) 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulinpräparationen mit erhöhter Stabilität
TWI391399B (zh) 2005-05-25 2013-04-01 Hoffmann La Roche 測定溶離多肽之鹽濃度之方法
US7879332B2 (en) * 2005-09-01 2011-02-01 Plasma Technologies, Llc Ultra-high yield intravenous immune globulin preparation
US8293242B2 (en) * 2005-09-01 2012-10-23 Plasma Technologies, Llc Ultra-high yield of alpha-1-anti-trypsin
US20070049732A1 (en) * 2005-09-01 2007-03-01 Zurlo Eugene J Ultra-high yield intravenous immune globulin preparation
CN100362022C (zh) * 2005-11-07 2008-01-16 中国人民解放军第二军医大学 海螵蛸多糖cps-1及其制备方法和用途
US20070128693A1 (en) * 2005-12-06 2007-06-07 Advantek Serum Laboratories Limited3/F Method for the inactivation and removal of dengue virus from biological samples
WO2007136327A1 (en) * 2006-05-22 2007-11-29 Ge Healthcare Bio-Sciences Ab A method of producing igg
US20100158893A1 (en) * 2008-12-19 2010-06-24 Baxter International Inc. Systems and methods for obtaining immunoglobulin from blood
EA023382B1 (ru) 2009-05-27 2016-05-31 Бакстер Интернэшнл Инк. Способ получения высококонцентрированного препарата иммуноглобулина для подкожного применения
WO2011073235A1 (en) 2009-12-18 2011-06-23 Csl Ltd. Method of purifying polypeptides
US20130116413A1 (en) * 2009-12-29 2013-05-09 Dr. Reddy's Laboratories, Inc. Purification of proteins
ES2716088T3 (es) 2010-02-04 2019-06-10 Csl Behring Ag Preparado de inmunoglobulina
EP2361636A1 (de) 2010-02-26 2011-08-31 CSL Behring AG Immunglobulinpräparat und Aufbewahrungssystem für ein Immunglobulinpräparat
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
US8772462B2 (en) 2010-05-26 2014-07-08 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
BR112014004445B1 (pt) * 2011-08-26 2022-11-22 Takeda Pharmaceutical Company Limited Método para reduzir conteúdo de fator xi e/ou fator xia em uma composição de imunoglobulina
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
US8986670B2 (en) 2012-02-29 2015-03-24 Baxter International Inc. IgG stimulated remyelination of peripheral nerves
AU2013203043B2 (en) 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
FR3018450B1 (fr) * 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
CN104231065A (zh) * 2014-09-09 2014-12-24 青岛康大食品有限公司 兔血中球蛋白的纯化制备方法
WO2017066683A1 (en) 2015-10-15 2017-04-20 Plasma Technologies, Llc Methods for extracting proteins from blood plasma
CA3012694A1 (en) * 2016-02-03 2017-08-10 Plasma Technologies, Llc Methods for extracting proteins from a blood-based material
US10815270B1 (en) * 2019-09-20 2020-10-27 Plasma Technologies, Llc Compositions and methods for high efficiency protein precipitation
US10836790B1 (en) * 2019-09-20 2020-11-17 Plasma Technologies, Llc Therapeutic protein compositions and methods
MX2022011950A (es) 2020-03-31 2022-10-21 Takeda Pharmaceuticals Co Metodo para producir una preparacion de inmunoglobulina a partir de plasma con reduccion del inhibidor de c-1.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
DE59009020D1 (de) 1990-03-22 1995-06-08 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verträglichen Immunglobulin-G-Präparates.
DE4118912C1 (de) * 1991-06-08 1992-07-02 Biotest Pharma Gmbh, 6072 Dreieich, De
ES2129076T5 (es) 1993-12-27 2003-05-16 Zlb Bioplasma Ag Procedimiento para la preparacion de un concentrado de inmunoglobulina g anti-d y composicion farmaceutica que lo contiene.
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
US5886154A (en) * 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
IL121900A (en) * 1997-10-07 2001-12-23 Omrix Biopharmaceuticals Ltd A method for the purification of immunoglobulins
KR100501263B1 (ko) * 1998-06-09 2005-07-18 스태튼스 세룸 인스티튜트 정맥 주사용 면역글로불린의 제조 방법 및 그 외의 면역글로불린 제품
ES2527915T3 (es) * 1998-06-09 2015-02-02 Csl Behring Ag Producto de inmunoglobulina G (IgG) líquido
DE19923027C2 (de) * 1999-05-19 2002-09-19 Aventis Behring Gmbh Verfahren zur Inaktivierung von Viren

Also Published As

Publication number Publication date
EP1268551A2 (de) 2003-01-02
PT1268551E (pt) 2004-07-30
US20030143222A1 (en) 2003-07-31
DE60102144T2 (de) 2004-10-28
SE0001128D0 (sv) 2000-03-30
BR0109740A (pt) 2003-02-04
US6835379B2 (en) 2004-12-28
DE60102144D1 (de) 2004-04-01
RU2002124857A (ru) 2004-02-20
CN1419566A (zh) 2003-05-21
AU7390701A (en) 2001-10-08
BRPI0109740B8 (pt) 2021-05-25
CA2402784A1 (en) 2001-10-04
WO2001072844A2 (en) 2001-10-04
JP2003530326A (ja) 2003-10-14
EP1268551B1 (de) 2004-02-25
AU2001273907B2 (en) 2006-02-02
WO2001072844A3 (en) 2002-04-11
TR200400701T4 (tr) 2004-05-21
RU2266914C2 (ru) 2005-12-27
BR0109740B1 (pt) 2015-01-06
IL151667A0 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
ATE260297T1 (de) Eine methode zur herstellung von igg
RU2337109C2 (ru) ПРЕПАРАТ ИММУНОГЛОБУЛИНА IgG И СПОСОБ ЕГО ПОЛУЧЕНИЯ
ATE346861T1 (de) Verfahren zur reinigung und isolierung von viren, aus pflanzenquellen
US5886154A (en) Chromatographic method for high yield purification and viral inactivation of antibodies
US6069236A (en) Immunoglobulin G concentrate for therapeutic use and process for producing said concentrate
JPH0231689A (ja) 百日咳トキシンの精製法
AT402607B (de) Verfahren zur gewinnung einer ein labiles verfahren zur gewinnung einer ein labiles protein enthaltenden zusammensetzung protein enthaltenden zusammensetzung
US5834420A (en) Fibrinogen concentrate obtained from blood plasma, process and plant for its preparation
TW245768B (en) Method for killing microorganisms
JPS5944320A (ja) Ｃ１不活性化剤の調製方法
CA2482512A1 (en) Improved viral purification methods
MX9701183A (es) Procedimiento de preparacion del virus gripal, antigenos obtenidos y sus aplicaciones.
KR102382662B1 (ko) 방법
DK1718673T3 (da) Fremgangsmåde til rensning af albumin omfattende et nanofiltreringstrin, oplösning og sammensætning til terapeutisk anvendelse, som indeholder det
EP0309787A3 (en) Process for producing a highly purified, virus-free and biologically active transferrin preparation
AT403477B (de) Biologisches material frei von viralen und molekularen pathogenen und verfahren zur herstellung
RU2006118024A (ru) Способ удаления вирусов из жидкой композиции, содержащей фактор vii
CN1181782A (zh) 一种从生物原料中制备因子ix的方法
AT381026B (de) Verfahren zur herstellung einer nebenwirkungsfreien igg-immunglobulinloesung fuer die intravenoese applikation
AU726808B2 (en) Process for reducing the concentration of viral and molecular pathogens in a biological material
TWI526214B (zh) 缺乏一種以上致血栓因子的血漿製品之製備方法
CN101024824A (zh) 一种从生物样品中将登革病毒灭活和去除的方法
AU726999B2 (en) Process for reducing the concentration of viral and molecular pathogens in a biological material
CN115304668A (zh) 一种高效生产α1-抗胰蛋白酶的方法
MXPA06009678A (es) Metodo para proporcionar una preparacion purificada de anticuerpo con virus inocuos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties